Stem Cell Transplantation is fastest growing segment fueling the growth of Bone Marrow Transplant Market

The global Bone Marrow Transplant Market is estimated to be valued at US$ 6,303.19 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview: Bone marrow transplant procedure involves replacing damaged or destroyed bone marrow with healthy bone marrow from a donor. Bone marrow transplant is widely used for the treatment of various types of blood cancers, anemia, and immune system disorders. The stem cells found in bone marrow also hold tremendous potential for treating various non-malignant diseases.

Market key trends: Stem cell transplantation is fast emerging as an important segment boosting the growth of the bone marrow transplant market. Advancements in stem cell research have enabled the isolation and transplantation of hematopoietic stem cells from peripheral blood, umbilical cord blood, and placenta tissue. This has opened new avenues for stem cell therapies in regenerative medicine and treatment of diseases beyond cancer. Growing success of experimental stem cell therapies for conditions such as diabetes, heart disease, neurological disorders is generating significant interest among researchers and industry players. Increased funding in this area is expected to drive the demand for stem cell collection/banking and transplantation services.
Segment Analysis
The global bone marrow transplant market is segmented based on product, technology, indication, and end user. By product, the allogeneic bone marrow transplant segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Allogeneic transplants use donor stem cells matched to the recipient and have higher success rates compared to autologous transplants for certain conditions like leukemia.

Key Takeaways
The global Bone Marrow Transplant Market Share  is expected to witness high growth, exhibiting CAGR of 4.0% over the forecast period 2023 to 2030, due to increasing prevalence of hematological malignancies and solid tumors.

Regional analysis
North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to the presence of advanced healthcare facilities, availability of skilled professionals, and high adoption of bone marrow transplant procedures in the region.

Key players
Key players operating in the bone marrow transplant market are Lonza, Merck KgaA, Sanofi, AllCells, STEMCELL Technologies Inc., Charles River Laboratories, Beike Biotechnology Co., Ltd., FUJIFILM Cellular Dynamics, Inc., CORESTEM, Inc., Gamida Cell, Lifeline Cell Technology, Mesoblast Ltd, and PromoCell GmbH. The market is consolidated with few global players operating in the market.

Read More,

https://www.insightprobing.com/bone-marrow-transplant-market-trends-size-and-share-analysis/